Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study.
about
Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Safety, Tolerability and Pharm ...... trolled, First-in-Human Study.
@en
Safety, Tolerability and Pharm ...... trolled, First-in-Human Study.
@nl
type
label
Safety, Tolerability and Pharm ...... trolled, First-in-Human Study.
@en
Safety, Tolerability and Pharm ...... trolled, First-in-Human Study.
@nl
prefLabel
Safety, Tolerability and Pharm ...... trolled, First-in-Human Study.
@en
Safety, Tolerability and Pharm ...... trolled, First-in-Human Study.
@nl
P2093
P2860
P1476
Safety, Tolerability and Pharm ...... ntrolled, First-in-Human Study
@en
P2093
Glen Wunderlich
Holger Rosenbrock
Karl-Heinz Liesenfeld
Klaus-Peter Kammerer
Michael Desch
Sophia Goetz
P2860
P2888
P304
P356
10.1007/S13318-017-0440-Z
P577
2018-04-01T00:00:00Z